Skip to main content
Clinical Trials/NCT05343494
NCT05343494
Completed
Not Applicable

Maternal Health Diabetes Prevention Project Pilot Study

Tulane University1 site in 1 country20 target enrollmentApril 4, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Gestational Diabetes
Sponsor
Tulane University
Enrollment
20
Locations
1
Primary Endpoint
Fidelity - sessions attended
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

The aim of this project is to use the Exploration, Preparation, Implementation, Sustainment (EPIS) framework to collect pilot data on the implementation of a Diabetes Prevention Program-like intervention in the Women, Infants, and Children (WIC) program.

Detailed Description

In this study, investigators will pilot a 2-month Diabetes Prevention Program-like program (delivered by WIC staff) to 20 women with recent gestational diabetes (6 weeks to 12 months postpartum) who receive WIC services. The goal of this pilot is to evaluate the feasibility, acceptability, appropriateness, fidelity of implementing this intervention in the setting of WIC clinics and feasibility of conducting a larger-scale study.

Registry
clinicaltrials.gov
Start Date
April 4, 2022
End Date
October 5, 2022
Last Updated
3 years ago
Study Type
Interventional
Study Design
Single Group
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Age ≥18 years
  • 6 weeks to 12 months postpartum
  • Medical record documented diagnosis of GDM during most recent pregnancy
  • Access to a device that can access the internet
  • English speaking

Exclusion Criteria

  • Pregnant or planning to become pregnant in the next two months
  • Planning to move out of the area in the next two months
  • Self-report of diagnosed diabetes
  • Use of glucose-lowering medications
  • Plasma glucose \>200 mg/dL and classic symptoms of hyperglycemia (thirst, polyuria, weight loss, blurry vision) or HbA1c \>6.5% (based on screening visit blood draw)
  • Unable or unwilling to provide informed consent

Outcomes

Primary Outcomes

Fidelity - sessions attended

Time Frame: 8-week intervention

Number of sessions attended throughout the 8 week intervention

Secondary Outcomes

  • Fidelity - sessions held(8-week intervention)
  • Fidelity - session content(8-week intervention)
  • Intervention feasibility(2-month data collection visit)
  • Intervention appropriateness(2-month data collection visit)
  • Intervention acceptability(2-month data collection visit)

Study Sites (1)

Loading locations...

Similar Trials